share_log

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Director Warden Kathy J

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Director Warden Kathy J

默沙東 | 4：持股變動聲明-董事 Warden Kathy J
美股sec公告 ·  06/05 03:03
牛牛AI助理已提取核心訊息
On May 31, 2024, Kathy J Warden, associated with Northrop Grumman Corp, executed a transaction involving Merck & Co., Inc. (MRK) common stock. Following the transaction, Warden holds a total of 500 shares of Merck & Co. directly. The nature of the transaction and the number of shares involved were not disclosed, but the post-transaction holdings suggest a significant investment in the pharmaceutical company.
On May 31, 2024, Kathy J Warden, associated with Northrop Grumman Corp, executed a transaction involving Merck & Co., Inc. (MRK) common stock. Following the transaction, Warden holds a total of 500 shares of Merck & Co. directly. The nature of the transaction and the number of shares involved were not disclosed, but the post-transaction holdings suggest a significant investment in the pharmaceutical company.
2024年5月31日，與northrop grumman corp相關的Kathy J Warden進行了一項涉及Merck & Co.，Inc.（MRK）普通股的交易。交易後，Warden直接持有Merck & Co.的500股。交易的性質和涉及的股票數量沒有透露，但交易後的持股量表明瞭對這家藥品公司的重大投資。
2024年5月31日，與northrop grumman corp相關的Kathy J Warden進行了一項涉及Merck & Co.，Inc.（MRK）普通股的交易。交易後，Warden直接持有Merck & Co.的500股。交易的性質和涉及的股票數量沒有透露，但交易後的持股量表明瞭對這家藥品公司的重大投資。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。